Punctin Inhibitors
Punctin inhibitors are a spectrum of chemicals tailored to influence cellular adhesion, migration, and relevant signaling cascades. Although not directly targeting Punctin, these compounds provide the avenue to manipulate Punctin's functionalities by adjusting the underlying cellular machinery. For instance, Latrunculin A and Cytochalasin D, which act on the actin cytoskeleton, offer the potential to curtail Punctin's adhesion-centric roles by reshaping the cellular structural framework.
Compounds like Wortmannin, LY294002, and PD98059, which act as kinase inhibitors, deliver another dimension of Punctin regulation. By dictating cellular signaling associated with growth, stress responses, and adhesion, these inhibitors redefine the cellular signaling milieu, presenting scenarios where Punctin's function could be altered. This showcases the tactic of indirectly managing Punctin by manipulating the broader cellular landscape.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Disrupts actin filaments which may indirectly reduce Punctin's adhesion-associated functions by altering the cytoskeletal framework. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Binds to actin filaments, preventing polymerization. This may disturb Punctin's involvement in cell adhesion by destabilizing structural support. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibits myosin II. As myosin and actin interactions underlie many adhesion processes, Punctin's function may be impacted by destabilizing these interactions. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
By inhibiting ROCK, it affects actin dynamics. This can indirectly impair Punctin's role in cellular adhesion by altering the cellular structural dynamics. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Inhibits Cdc42, another key GTPase. This can affect cellular morphology and adhesion, potentially compromising Punctin's function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As a PI3K inhibitor, it impacts pathways linked to cellular growth and adhesion, which may indirectly modify the cellular environment in which Punctin functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, it alters cell survival and growth signals that might indirectly influence Punctin's role in adhesion processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which affects downstream ERK signaling. This can modify cell signaling environments possibly influencing Punctin-mediated adhesion. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, it alters stress and inflammatory responses which might impact cellular states associated with Punctin's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By inhibiting p38 MAPK, it modulates cellular responses to stress and inflammation, potentially influencing environments in which Punctin operates. | ||||||